机译:人ATP结合盒转运蛋白ABCB1和ABCG2在癌细胞系中赋予组蛋白脱乙酰酶6抑制剂Ricolinostat(ACY-1215)的抗性
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Molecular Medicine Research Center College of Medicine Chang Gung University;
Laboratory of Cell Biology Center for Cancer Research National Cancer Institute NIH;
Laboratory of Cell Biology Center for Cancer Research National Cancer Institute NIH;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Department of Chemistry Tunghai University;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Department of Chemistry Tunghai University;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Laboratory of Cell Biology Center for Cancer Research National Cancer Institute NIH;
ABCB1; ABCG2; Multidrug resistance; HDAC6; Ricolinostat;
机译:人ATP结合盒转运蛋白ABCB1和ABCG2在癌细胞系中赋予组蛋白脱乙酰酶6抑制剂Ricolinostat(ACY-1215)的抗性
机译:人ATP结合盒式转运蛋白。 ABCG2赋予对组蛋白脱乙酰基酶和磷脂酰肌醇3-激酶的双重抑制剂CUDC-907的抗性。
机译:人ATP结合盒式转运蛋白ABCB1赋予对Volasertib(BI 6727),Polo样激酶1的选择性抑制剂的抗性。
机译:三环抗抑郁药阿米替林通过抑制组蛋白脱乙酰基酶抑制D-cyclin反式激活并诱导骨髓瘤细胞凋亡:体外和计算机证据。
机译:葫芦素风格的雌酮类似物作为人ATP结合盒式蛋白的新型抑制剂(ABCB1和ABCC1)的表征
机译:组蛋白脱乙酰基酶抑制剂对肺癌A549和大肠癌HCT116细胞ATP结合盒转运蛋白的影响
机译:人ABCB1和ABCG2的过度表达降低了癌细胞对组蛋白脱乙酰酶6特异性抑制剂CITARINOSTAT的敏感性